Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Cytotoxic CD8 + T cells in cancer and cancer immunotherapyBritish journal of cancer, 2021-01, Vol.124 (2), p.359-367 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01048-4 ;PMID: 32929195Full text available |
|
2 |
Material Type: Article
|
Hallmarks of glycosylation in cancerOncotarget, 2016-06, Vol.7 (23), p.35478-35489Copyright: © 2016 Munkley and Elliott 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.8155 ;PMID: 27007155Full text available |
|
3 |
Material Type: Article
|
Mitochondrial apoptosis: killing cancer using the enemy withinBritish journal of cancer, 2015-03, Vol.112 (6), p.957-962 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 17, 2015 ;Copyright © 2015 Cancer Research UK 2015 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2015.85 ;PMID: 25742467 ;CODEN: BJCAAIFull text available |
|
4 |
Material Type: Article
|
The lingering mysteries of metastatic recurrence in breast cancerBritish journal of cancer, 2021-01, Vol.124 (1), p.13-26 [Peer Reviewed Journal]The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01161-4 ;PMID: 33239679Full text available |
|
5 |
Material Type: Article
|
Deep learning in cancer pathology: a new generation of clinical biomarkersBritish journal of cancer, 2021-02, Vol.124 (4), p.686-696 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01122-x ;PMID: 33204028Full text available |
|
6 |
Material Type: Article
|
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyondBritish journal of cancer, 2021-01, Vol.124 (2), p.345-358 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01047-5 ;PMID: 32968207Full text available |
|
7 |
Material Type: Article
|
Achieving clinical success with BET inhibitors as anti-cancer agentsBritish journal of cancer, 2021-04, Vol.124 (9), p.1478-1490 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01321-0 ;PMID: 33723398Full text available |
|
8 |
Material Type: Article
|
Cold atmospheric plasma, a novel promising anti-cancer treatment modalityOncotarget, 2017-02, Vol.8 (9), p.15977-15995Copyright: © 2017 Yan et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.13304 ;PMID: 27845910Full text available |
|
9 |
Material Type: Article
|
Cancer health disparities in racial/ethnic minorities in the United StatesBritish journal of cancer, 2021-01, Vol.124 (2), p.315-332 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01038-6 ;PMID: 32901135Full text available |
|
10 |
Material Type: Article
|
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewBritish journal of cancer, 2015-03, Vol.112 Suppl 1 (S1), p.S92-S107 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 31, 2015 ;Copyright © 2015 Cancer Research UK 2015 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2015.48 ;PMID: 25734382 ;CODEN: BJCAAIFull text available |
|
11 |
Material Type: Article
|
Targeting folate receptor alpha for cancer treatmentOncotarget, 2016-08, Vol.7 (32), p.52553-52574Copyright: © 2016 Cheung et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.9651 ;PMID: 27248175Full text available |
|
12 |
Material Type: Article
|
Artificial intelligence in oncology: current applications and future perspectivesBritish journal of cancer, 2022-01, Vol.126 (1), p.4-9 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01633-1 ;PMID: 34837074Full text available |
|
13 |
Material Type: Article
|
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progressionBritish journal of cancer, 2019-01, Vol.120 (1), p.16-25 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2018 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-018-0333-1 ;PMID: 30413826Full text available |
|
14 |
Material Type: Article
|
Hallmarks of cancer stem cell metabolismBritish journal of cancer, 2016-06, Vol.114 (12), p.1305-1312 [Peer Reviewed Journal]Copyright Nature Publishing Group Jun 14, 2016 ;Copyright © 2016 Cancer Research UK 2016 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2016.152 ;PMID: 27219018 ;CODEN: BJCAAIFull text available |
|
15 |
Material Type: Article
|
IDH mutation in glioma: molecular mechanisms and potential therapeutic targetsBritish journal of cancer, 2020-05, Vol.122 (11), p.1580-1589 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0814-x ;PMID: 32291392Full text available |
|
16 |
Material Type: Article
|
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumoursBritish journal of cancer, 2015-07, Vol.113 (3), p.365-371 [Peer Reviewed Journal]Copyright Nature Publishing Group Jul 28, 2015 ;Copyright © 2015 Cancer Research UK 2015 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2015.233 ;PMID: 26151455 ;CODEN: BJCAAIFull text available |
|
17 |
Material Type: Article
|
How promising is phototherapy for cancer?British journal of cancer, 2020-09, Vol.123 (6), p.871-873 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0926-3 ;PMID: 32587359Full text available |
|
18 |
Material Type: Article
|
Antibody-drug conjugates--an emerging class of cancer treatmentBritish journal of cancer, 2016-02, Vol.114 (4), p.362-367 [Peer Reviewed Journal]Copyright Nature Publishing Group Feb 16, 2016 ;Copyright © 2016 Cancer Research UK 2016 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2015.435 ;PMID: 26742008 ;CODEN: BJCAAIFull text available |
|
19 |
Material Type: Article
|
Immune checkpoint inhibitor combinations-current and emerging strategiesBritish journal of cancer, 2023-04, Vol.128 (8), p.1415-1417 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Limited 2023. ;The Author(s), under exclusive licence to Springer Nature Limited 2023 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02181-6 ;PMID: 36747017Full text available |
|
20 |
Material Type: Article
|
Principles and mechanisms of non-genetic resistance in cancerBritish journal of cancer, 2020-02, Vol.122 (4), p.465-472 [Peer Reviewed Journal]2019© The Author(s), under exclusive licence to Cancer Research UK 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0648-6 ;PMID: 31831859Full text available |